Navigation Links
PDL BioPharma to Announce Third Quarter 2013 Financial Results on November 6, 2013
Date:10/28/2013

INCLINE VILLAGE, Nev., Oct. 28, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its third quarter 2013 financial results for the period ended September 30, 2013, on Wednesday, November 6, 2013, after market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results.  A slide presentation relating to the call will be available via the webcast link on the PDL website.

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

Conference Call Details

To access the live conference call via phone, please dial (800) 668-4132 from the United States and Canada or (224) 357-2196 internationally. The conference ID is 93070209. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately one hour after the call through November 12, 2013, and may be accessed by dialing (855) 859-2056 from the United States and Canada or (404) 537-3406 internationally. The replay passcode is 93070209.

To access the live and subsequently archived webcast of the conference call, go to the Company's website at http://www.pdl.com and go to "Events & Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.

About PDL BioPharma

PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL p
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regeneron Named Top Employer in the Global Biopharmaceutical Industry for the Second Year in a Row
2. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
3. Enteris BioPharma and Nordic BioSciences KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris Proprietary Oral Drug Delivery and Manufacturing Platform
4. CDISC and TransCelerate BioPharma Inc. Announce Landmark Asthma Data Standard Released for Public Review
5. Benu BioVentures to Finance Early Biopharmaceutical Clinical Development
6. Therapure Biopharma Inc. wins a 2013 CMO Leadership Award in All 5 Categories: Quality, Reliability, Innovation, Productivity and Regulatory
7. Recently Patented Technology Poised To Disrupt The Plasma Biopharmaceutical Market
8. Life Cycle Management of Biopharmaceuticals, New Life Science Webinar Hosted by Xtalks
9. KBI Biopharma Selects Freeslate’s Biologics Formulation System for Early and Late Stage Drug Development
10. 6th BSMA Annual Executive Summit to Address the Supply Chain Challenges and Solutions of Biopharma
11. Before the Bell Scans: Hologic Inc., St. Jude Medical Inc., ResMed Inc., and Navidea Biopharmaceuticals Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... 14, 2014 As part of ... significant investments in its network and logistics capabilities ... chain and the complex requirements of the industry. ... on customized logistics and transportation, and includes opening ... facilities. There will be an emphasis on Customer ...
(Date:11/15/2014)... Denver, Colorado (PRWEB) November 14, 2014 ... leading provider of proprietary, cloud-based analytics, and scientific ... results for the third quarter ended September 30, ... Quarter 2014 Highlights, ,     CannLabs – ... in Las Vegas, Nevada. ,     CannLabs – ...
(Date:11/15/2014)... Omnia Education , the leading ... announced the launch of a nationwide educational series on ... pain is the most common breast symptom for which ... report mild breast pain while evidence shows more than ... Along with breast pain and tenderness, FBC may also ...
(Date:11/15/2014)... Biofuels will present at CleanEquity Monaco 2015 on March 5th ... . Logo - http://photos.prnewswire.com/prnh/20141114/158674LOGO ... by Innovator Capital, the London based ... Prince Albert II of Monaco,s ... Monte-Carlo SBM, Oceanographic Museum of Monaco , ...
Breaking Biology Technology:QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2CannLabs Announces Third Quarter 2014 Results. 2CannLabs Announces Third Quarter 2014 Results. 3CannLabs Announces Third Quarter 2014 Results. 4CannLabs Announces Third Quarter 2014 Results. 5Omnia Education Launches Nationwide Educational Series on Breast Pain and Fibrocystic Breast Changes Affecting Half of all Women 2Omnia Education Launches Nationwide Educational Series on Breast Pain and Fibrocystic Breast Changes Affecting Half of all Women 3Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2
... 25, 2012 Aviir Diagnostic Laboratory announced today ... with MultiPlan, Inc. for ancillary diagnostics laboratory testing. ... PHCS and PHCS Savility Networks. Aviir ... from the Stanford University School of Medicine to ...
... The rise of the corporate venture fund and the ... themes at BioTrinity, the-premier European biopartnering and investment conference ... comprehensive support for bioscience businesses in the Oxford and ... day of the conference saw senior figures from Merck ...
... well-respected, independent, third-party laboratory has tested for Tuberculosis (TB) ... (BioNanoPore) test kits and achieved the detection of ... culture times for conventional technologies take a minimum of ... concurrent tests for TB at the same facility, using ...
Cached Biology Technology:Aviir Laboratories Announce National Agreement With MultiPlan 2Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity 2Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity 3NanoLogix Provides Testing and Operations Update 2NanoLogix Provides Testing and Operations Update 3
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... a child, it was fascinating to put a flashlight ... through the hand. Washington University in St. Louis engineers ... the body,s tissues to improve imaging of cancerous tissues ... PhD, the Gene K. Beare Distinguished Professor of Biomedical ... is applying a novel time-reversal technology that allows researchers ...
(Date:10/31/2014)... that endangered musk deer still live in Nuristan Province ... by poachers: Musk deer scent glands are more valuable ... of the journal Oryx , NEW YORK ... its last confirmed sighting, a strange deer with vampire-like ... northeast Afghanistan according to a research team led by ...
Breaking Biology News(10 mins):NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3Improving imaging of cancerous tissues by reversing time 2Strange, fanged deer persists in Afghanistan 2
... a molecule that plays a role in the battle plants ... for lunch. The group led by Professor Clarence A. "Bud" ... act like a hormone, signaling to the rest of the ... an infection. They also discovered the receptor protein to which ...
... Researchers have developed a new technique for creating human ... embryonic stem cells. The fusion causes the adult cells ... have the developmental characteristics of human embryonic stem cells. ... somatic cell nuclear transfer (SCNT), a method that is ...
... in prehistoric rocks suggest Earth was not ice-bound , ... rock formations has turned up strong evidence on the ... The study appears in the Sept. 29 Science Express. ... of earth sciences in the USC College of Letters, ...
Cached Biology News:A new molecule discovered in the battle between plants and disease 2Researchers devise new technique for creating human stem cells 2Researchers devise new technique for creating human stem cells 3Researchers devise new technique for creating human stem cells 4Study casts doubt on 'Snowball Earth' theory 2
... Guava EasyCyte system is the first and ... built-in 96-well microplate sampling (with tube options). ... and compounds quickly and easily, without the ... the carryover issues found with other detachable ...
... sequencing and finishing services are tailored ... perform large-scale 5' screening or full ... considerable experience with large-scale genome projects ... an ideal cDNA outsourcing solution. In ...
Shotgun library construction and high-throughput DNA sequencing of microbial genomes, BACs, adenoviruses, phosmids and cosmids. LIMS tracking utilizing Geospiza's Finch system....
... XAB2 (amino terminus) XAB2 (XPA-binding protein ... with XPA. Immunoprecipitation experiments have also demonstrated ... the transcription-coupled repair-specific proteins CSA and CSB ... Microinjection experiments with XAB2 antibodies resulted in ...
Biology Products: